Literature DB >> 23370673

Endocytic pathway of exogenous iron-loaded ferritin in intestinal epithelial (Caco-2) cells.

Elmer Antileo1, Carolina Garri, Victoria Tapia, Juan Pablo Muñoz, Mario Chiong, Francisco Nualart, Sergio Lavandero, Juan Fernández, Marco T Núñez.   

Abstract

Ferritin, a food constituent of animal and vegetal origin, is a source of dietary iron. Its hollow central cavity has the capacity to store up to 4,500 atoms of iron, so its potential as an iron donor is advantageous to heme iron, present in animal meats and inorganic iron of mineral or vegetal origin. In intestinal cells, ferritin internalization by endocytosis results in the release of its iron into the cytosolic labile iron pool. The aim of this study was to characterize the endocytic pathway of exogenous ferritin absorbed from the apical membrane of intestinal epithelium Caco-2 cells, using both transmission electron microscopy and fluorescence confocal microscopy. Confocal microscopy revealed that endocytosis of exogenous AlexaFluor 488-labeled ferritin was initiated by its engulfment by clathrin-coated pits and internalization into early endosomes, as determined by codistribution with clathrin and early endosome antigen 1 (EEA1). AlexaFluor 488-labeled ferritin also codistributed with the autophagosome marker microtubule-associated protein 1 light chain 3 (LC3) and the lysosome marker lysosomal-associated membrane protein 2 (LAMP2). Transmission electron microscopy revealed that exogenously added ferritin was captured in plasmalemmal pits, double-membrane compartments, and multivesicular bodies considered as autophagosomes and lysosomes. Biochemical experiments revealed that the lysosome inhibitor chloroquine and the autophagosome inhibitor 3-methyladenine (3-MA) inhibited degradation of exogenously added (131)I-labeled ferritin. This evidence is consistent with a model in which exogenous ferritin is internalized from the apical membrane through clathrin-coated pits, and then follows a degradation pathway consisting of the passage through early endosomes, autophagosomes, and autolysosomes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23370673     DOI: 10.1152/ajpgi.00472.2012

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  7 in total

1.  Pancreatic α-Amylase Controls Glucose Assimilation by Duodenal Retrieval through N-Glycan-specific Binding, Endocytosis, and Degradation.

Authors:  Kimie Date; Ayano Satoh; Kaoruko Iida; Haruko Ogawa
Journal:  J Biol Chem       Date:  2015-05-28       Impact factor: 5.157

2.  A Synthetic Ferritin Core Analog Functions as a Next-Generation Iron Supplement.

Authors:  James F Collins
Journal:  J Nutr       Date:  2022-03-03       Impact factor: 4.798

Review 3.  Ferritin: the protein nanocage and iron biomineral in health and in disease.

Authors:  Elizabeth C Theil
Journal:  Inorg Chem       Date:  2013-10-08       Impact factor: 5.165

4.  Mechanisms of Iron Uptake from Ferric Phosphate Nanoparticles in Human Intestinal Caco-2 Cells.

Authors:  Antonio Perfecto; Christine Elgy; Eugenia Valsami-Jones; Paul Sharp; Florentine Hilty; Susan Fairweather-Tait
Journal:  Nutrients       Date:  2017-04-04       Impact factor: 5.717

Review 5.  Intestinal epithelial cell polarity defects in disease: lessons from microvillus inclusion disease.

Authors:  Kerstin Schneeberger; Sabrina Roth; Edward E S Nieuwenhuis; Sabine Middendorp
Journal:  Dis Model Mech       Date:  2018-02-13       Impact factor: 5.758

Review 6.  The challenges of oral drug delivery via nanocarriers.

Authors:  Jonas Reinholz; Katharina Landfester; Volker Mailänder
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

7.  Ferroportin mediates the intestinal absorption of iron from a nanoparticulate ferritin core mimetic in mice.

Authors:  Mohamad F Aslam; David M Frazer; Nuno Faria; Sylvaine F A Bruggraber; Sarah J Wilkins; Cornel Mirciov; Jonathan J Powell; Greg J Anderson; Dora I A Pereira
Journal:  FASEB J       Date:  2014-04-28       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.